LiNCS launches Pathfinder Lab, ushering in a new era of precision cancer care in the Philippines
Pathfinder Lab will provide Filipinos with access to advanced genomic testing, revolutionizing cancer care
By MB Lifestyle
Linking Network for Cancer Services Inc. (LiNCS) has marked a groundbreaking milestone in Philippine healthcare with the inauguration of its state-of-the-art genomics facility, Pathfinder Lab. Located at Unit 7D, Strata 100 Building, Emerald Avenue, Ortigas Central Business District, Pasig City, Pathfinder Lab aims to provide Filipinos with access to advanced genomic testing—revolutionizing cancer care and placing personalized treatment at the forefront.
“This is more than just the opening of a laboratory; it’s the opening of a new chapter in Philippine healthcare,” said Dr Necy Juat of L!NCS. “Pathfinder Lab represents our unwavering commitment to providing equitable, world-class cancer care for every Filipino patient. We are proud to bring this groundbreaking technology home, making precision medicine accessible and empowering doctors to deliver more targeted and effective treatments.”
Pathfinder Lab utilizes Next-Generation Sequencing (NGS) technology, which maps the genetic code of a tumor, enabling physicians to:
- Choose medications that directly target the specific cancer.
- Avoid administering drugs that may be ineffective for the patient’s cancer type.
- Minimize side effects.
- Act faster and with greater confidence.
This personalized approach empowers patients and their families with knowledge and hope, offering not only a stronger chance of recovery but also a more positive experience throughout their cancer journey.
The launch of Pathfinder Lab stands as a testament to LiNCS’ dedication to innovation and its mission to improve the lives of Filipinos battling cancer. It is also a significant step toward fulfilling the goals of the National Integrated Cancer Control Act, which seeks to improve access to high-quality cancer care across the country.
To learn more about genomic testing and its potential to transform cancer care, visit www.lincsconsulting.com.